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Abstract The cloning of full length cDNA for the translocon-
associated protein K subunit, previously called signal sequence
receptor K, is reported as a result of differential display
experiments in search of genes induced by granulocyte-macro-
phage colony-stimulating factor. Its messenger RNA was more
abundant in growing cells than in either factor-deprived cells or
quiescent cells and comprised four species, each having micro-
heterogeneity, as a result of complex alternative polyadenylation
apparently dependent on arrays of non-canonical polyadenyla-
tion signals. Radiation hybrid mapping of the gene showed that
the gene is on the short arm of chromosome 6.
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1. Introduction
Granulocyte-macrophage colony-stimulating factor (GM-
CSF) is a cytokine produced by a variety of cell types in
response to speci¢c stimuli. It stimulates the proliferation of
myeloid and endothelial cells and regulates the functions of
terminally di¡erentiated myeloid cells (reviewed by Gasson
[1]). When bound to the ligand, the cellular receptor for
GM-CSF transduces a signal into the cell through a number
of pathways, e.g. the JAK2 tyrosine kinase mitogen-activated
protein kinase pathway [2^6], the JAK2 signal transducer and
activator of transcription ¢ve proteins pathway and the phos-
phatidylinositol 3-phosphate kinase pathway. In addition, a
number of other kinases are known to be phosphorylated
on GM-CSF stimulation [7^10].
GM-CSF stimulation leads to the induction of transcription
of a number of genes including c-fos, c-jun, junB [11,12],
c-myc [13], egr-1 [14], c-fms [15] and lipoxygenase [16]. To
identify more genes that are induced by GM-CSF and thereby
facilitate our understanding of the GM-CSF function, we per-
formed the di¡erential display technique, which was recently
developed to clone genes expressed in one population of cells
but not in the other [17]. We found that translocon-associated
protein (TRAP) K is induced in a growth factor dependent
human myeloid cell line, TF-1, after stimulation with GM-
CSF. We also found that TRAP K messenger RNA
(mRNA) undergoes complex alternative polyadenylation.
Identi¢cation of a membrane protein residing in the endoplas-
mic reticulum (ER) as a GM-CSF-induced gene might repre-
sent a so far unvisited aspect of the GM-CSF function.
2. Materials and methods
2.1. Cells
The TF-1 cell line [18] and MG-63 osteosarcoma cell line [19] were
purchased from the American Type Culture Collection (Rockville,
MD, USA). TF-1 cells were cultured in medium supplemented with
25 ng/ml recombinant human GM-CSF (Immunex, Seattle, WA,
USA).
2.2. Di¡erential display
Di¡erential display was done principally by the method of Liang et
al. [17,20]. Northern blot hybridization was performed according to
the standard protocol [21]. Even loading of samples between the lanes
was veri¢ed by staining the blot with methylene blue.
2.3. Nucleotide sequence analyses
The nucleotide sequence was analyzed on both strands of the
cloned cDNAs utilizing either the Core Facility of UCLA or an
ABI Prism 377 sequencer (Perkin-Elmer, Norwalk, CT, USA). Either
the Dye Terminator Cycle Sequencing Ready Reaction kit or Dye
Primer Cycle Sequencing Ready Reaction kit (Perkin-Elmer, Nor-
walk, CT, USA) were used for the reaction.
2.4. Analyses of TRAP K cDNA
Using the primers designed from the sequence of the cloned, di¡er-
entially displayed fragment, rapid ampli¢cation of cDNA ends
(RACE) reactions were done in each direction with the Marathon
cDNA ampli¢cation kit (Clontech Lab., Palo Alto, CA, USA). Am-
pli¢ed cDNA bands were cloned into a plasmid vector and sequenced
from their adaptor end, enabling us to design primers to amplify full
length cDNA. The full length cDNA was then ampli¢ed, cloned into
the vector and sequenced. To analyze TRAP K transcripts, a 3P-
RACE reaction was performed using the same kit, starting from a
primer that was designed to anneal to the 5P-untranslated region of
the TRAP K cDNA. PCR fragments were then cloned and sequenced.
The nucleotide sequence of the full length cDNA has been deposited
in the GenBank database under accession number AF156965.
2.5. Flow cytometric analyses of the DNA content
Cells were harvested, rinsed with PBS and ¢xed with 66% methanol
in PBS. The cell cycle distribution was measured by incubating cells in
DNA staining solution (15 Wg/ml propidium iodide in PBS). Fluores-
cence was excited at 488 nm and measured at 575 nm using a FACS-
CAN £ow cytometer (Becton-Dickinson, San Jose, CA, USA). The
percentages of cells within the G1, S and G2/M phases of the cell cycle
were determined by analysis with the software provided by Becton-
Dickinson.
2.6. Radiation hybrid mapping
Radiation hybrid mapping was done with the GeneBridge 4 RH
panel purchased from Research Genetics (Huntsville, AL, USA). The
PCR products from the gene panel were analyzed on an agarose gel.
Results of two separate reactions were submitted to WICGR Map-
ping Service via internet (http://www-genome.wi.mit.edu/cgi-bin/
contig/rhmapper.pl), which gave us the computed result.
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3. Results
3.1. Di¡erential display
To isolate transcripts induced by GM-CSF, we set out to
analyze mRNA expression by the di¡erential display techni-
que. From the TF-1 cell line, which was initially established
from an erythroleukemic patient and exhibits multiple factor
dependence, we isolated RNA before and after 60 h depriva-
tion of GM-CSF. Using the di¡erential display technique, we
identi¢ed a band speci¢c to RNA from cells supplemented
with the factor. When used as a probe for a Northern blot
analysis, the DNA recovered from the band detected a 3.3 kb
band of which the expression was upregulated by GM-CSF
(Fig. 1). The DNA was cloned into a plasmid vector (called
R60 hereafter). Nucleotide sequence analysis of R60 and sub-
sequent searching of the GenBank revealed its identity with
one of two 3P-ends of reported decorin cDNA [22]. However,
this may not be an authentic cDNA end of decorin, since
Danielson et al. had noted that this cDNA end did not detect
bands matching the size of decorin mRNA in a Northern blot
analysis [23]. This fact prompted us to look further into the
R60 sequence.
3.2. Cloning of the full length cDNA
To obtain more sequence information on the transcript en-
compassing R60, we performed RACE reactions. Successfully
ampli¢ed and cloned, the full length cDNA had a predicted
open reading frame (ORF) encoding the previously reported
TRAP K at its 5P-end and included the R60 sequence at its 3P-
end (Fig. 2).
3.3. Expression pattern of TRAP K RNA
To determine if the cDNA that we cloned is expressed in
cells, we probed Northern blots with a 1.5 kbp fragment en-
compassing the whole coding region of the TRAP K cDNA.
As expected, the probe detected a 3.3 kb band which was of
the same size as the band detected with R60 and with the size
of the cDNA itself (Fig. 3b), suggesting that the cloned cDNA
roughly represented a full length fragment. Remarkably, the
probe also detected several bands of smaller sizes (see below).
Next, the expression pattern of TRAP K RNA was studied
under several experimental conditions. The induction pro¢le
of this gene by GM-CSF stimulation was examined. As ex-
pected, after deprivation and re-addition of GM-CSF, mRNA
levels of TRAP K in the TF-1 cells increased (Fig. 3a), verify-
ing that this gene is inducible. Notably, the induction was
more obvious for the shortest RNA species, which increased
by 24 h. To see if the expression level changes during the cell
cycle, the MG-63 osteosarcoma cell line was examined be-
cause it stops growing when either cultured under reduced
serum conditions or con£uent. In our cell cycle analyses using
this cell line, reduction of the serum concentration to 0.5%
resulted in increased G1 phase cells and decreased S and G2/
M phase cells by day two compared to the control condition
with 10% serum (Fig. 3c, 12 and 13). The G2/M phase cells
further decreased by day seven, suggesting that the cells were
arrested at the G1/S checkpoint (Fig. 3c, 14). Similarly, the
MG-63 cells that were con£uent for 7 days were mostly in the
G1 phase (Fig. 3c, 15). When the corresponding RNA sam-
ples from the MG-63 cells were analyzed, expression of TRAP
K mRNA gradually decreased in the low serum condition
(Fig. 3b, lanes 8^10) and was even less in the con£uent cells
(Fig. 3b, lane 11). These ¢ndings suggest that this gene is
downregulated in quiescent cells. Also in the MG-63 cells,
the change in the RNA level was most obvious for the short-
est band.
Fig. 1. Northern blot analyses of TF-1 RNA. 10 Wg of total cellular
RNA from factor-deprived TF-1 cells (lane 1) and TF-1 cells grow-
ing in GM-CSF-supplemented medium (lane 2) were separated in a
1% formaldehyde gel and transferred to a nylon membrane. DNA
eluted from a di¡erentially expressed band was labelled and hybrid-
ized to the membrane. The migration pattern of 28S and 18S ribo-
somal RNA is shown on the left. The staining of the 28S ribosomal
RNA on the blot is shown in the lower panel.
Fig. 2. Diagram showing the relationship of previously reported decorin cDNA to the TRAP K cDNA and related ESTs. The shaded area be-
tween sequences indicates identity between the sequences. TRAP K and decorin ORFs are represented by ¢lled and dotted boxes, respectively.
The primers used in the initial RACE reactions and subsequent ampli¢cation of the full length cDNA are depicted by arrowheads and arrows,
respectively. Two published 3P-ends of decorin cDNA are distinguished by a pattern ¢lling the region. The accession number of the previously
published TRAP K sequence (shown as TRAP K (embl)) is Z12830. The decorin sequences are from Krusius et al. [22]. An initial search of the
TIGR database with R60 found THC88165_1, searching the database with Z12830 returned THC212408.
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3.4. Analyzing variant transcripts
As the R60 probe, which represented the 3P-end of the
cDNA, hybridized only with the largest 3.3 kb band (data
not shown), the smaller bands detected with the 1.5 kb probe
might represent either related but distinct sequences, alterna-
tive polyadenylation or splicing of the mRNA that removes
the R60 sequence. The TRAP K transcripts were, therefore,
examined further. We performed a 3P-RACE reaction using a
primer designed to anneal to the 5P-untranslated region of the
TRAP K cDNA. The reaction gave ¢ve distinct bands (Fig.
4a), the largest of which matched the size of our full length
cDNA. Taking into account the length of a poly(A) tract, the
approximate sizes of these fragments matched those of the
observed bands in the Northern blot analyses. The sequences
of the cloned 3P-RACE fragments suggested a complex pat-
tern of alternative polyadenylation of this gene. The full
length transcript had an atypical polyadenylation signal se-
quence (AAUAAU) which was 30 bases upstream from the
beginning of the poly(A) tail. The clones derived from the
shortest band did not have the poly(A) tail and were not
analyzed further. Each of the remaining bands gave clones
with slightly di¡erent polyadenylation sites and hence sizes,
with variations of the polyadenylation signals (Fig. 4b, double
underlines). When compared to the full length cDNA se-
quence, these clones from the three bands all were predicted
to have a U-rich sequence downstream of the poly(A) site,
which is another requisite of a polyadenylation event [24]
(Fig. 4b, dotted underlines).
3.5. RH mapping
We performed PCR-based radiation hybrid mapping to lo-
cate chromosomally the human TRAP K gene. We found the
nearest neighbor of the TRAP K gene to be WI-4041, which is
assigned to the short arm of the sixth chromosome at 60 cR
from the telomere.
4. Discussion
Previously reported canine and human TRAP K cDNA
sequences did not have a poly(A) tail nor an authentic poly-
adenylation signal [25,26], quite similar to the shortest of our
3P-RACE product. In addition, our initial attempt to screen a
human cDNA library with the R60 probe also yielded clones
almost identical to R60 itself. These facts indicate a factor
intrinsic to the TRAP K gene hampering the cloning of the
full length cDNA by conventional methods. Utilizing the
RACE method, we successfully ampli¢ed the full length
cDNA for TRAP K. The sequence of the cDNA shows a
long 3P-untranslated region quite rich in short stretches of
homopyrimidines, which might predispose to the formation
of stem loops and other secondary structures. Our PCR re-
actions used highly stringent conditions and invariably yielded
a clear single band, which underscores the authenticity of our
cDNA.
Nearly every metazoan mRNA has a polyadenylation sig-
nal sequence 10^30 bases upstream of the actual polyade-
nylation site [24]. The signal sequence, AAUAAA, is strictly
conserved to be e⁄cient, with the only exception being
AUUAAA, resulting in 77% activity compared to the canon-
ical sequence [27]. Other types of substitutions are rare and
signi¢cantly reduce the polyadenylation e⁄ciency [27]. Strik-
ingly, none of the predicted polyadenylation signals in the
TRAP K transcripts were canonical. The shortest 1.2 kb
band contained the AUUAAA hexanucleotide, which might
explain the relative abundance of the shortest band in our
Northern blot analyses. Alternative polyadenylation in other
genes sometimes results in transcripts with an altered half-life
or intracellular localization [28]. Possibly, TRAP K might ex-
ploit the di¡erential e⁄ciency of these polyadenylation signals
to generate transcripts of di¡erent 3P-structures and hence
fates. Indeed, the induction of the TRAP K gene was most
obvious for the shortest band in our Northern blot analyses
(Fig. 3). Compared with the previous examples of alternative
polyadenylation [28], TRAP K is a unique entity in that it
utilizes arrays of signal sequences that are exclusively non-
canonical
TRAP K was initially isolated as a protein that exists within
a crosslinkable distance from the amino-terminal signal se-
quence of selected secreted polypeptides during their co-trans-
lational translocation into the microsome [25,29]. Although
antibodies directed against TRAP K were inhibitory to the
translocation process [30], Migliaccio et al. subsequently
showed that the protein was unessential for this process
[31]. TRAP K is a type I membrane protein residing in the
membrane of the ER and the nuclear envelope [25,32]. It
binds calcium in vitro [33]. Otherwise, the function of this
Fig. 3. Expression of the TRAP K gene. (a and b) A 1.5 kb cDNA
fragment encompassing the whole ORF of TRAP K was labelled
and hybridized to Northern blots (upper panels). Lower panels
show 18S ribosomal RNA of corresponding blots stained with
methylene blue. (a) Induction pro¢le of the TRAP K mRNA after
GM-CSF addition. RNA from cells before (lane 1) as well as 2, 4,
8, 24 and 48 h after GM-CSF addition (lanes 2^6, respectively) and
from growing cells (lane 7) were analyzed. (b) RNA from the MG-
63 cells in their rapidly growing state (lane 8), kept 2 and 7 days in
medium with 0.5% serum (lanes 9 and 10, respectively) and kept
con£uent for 7 days (lane 11) were analyzed. (c) Cell cycle analyses
of MG-63 cells. The cells were treated as in b and analyzed by £ow
cytometry. Panels 12^15 correspond to lanes 8^11 in b, respectively.
Calculated proportions of cells in each phase of the cell cycle are
shown.
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protein has remained unexplored. To our knowledge, induc-
tion of an ER-resident membrane protein by GM-CSF is a
novel ¢nding. In factor-stimulated cells, the protein synthesis
might reach a rate exceeding that of protein maturation in the
ER, resulting in the accumulation of improperly folded pro-
teins and subsequent an unfolded protein response (UPR)
[34]. The induction of TRAP K might thus relate to the
UPR. On the other hand, the induction might well be depend-
ent on pathways that are already known to be expedited by
GM-CSF. Recently, Brewer et al. have hypothesized that
growth factors regulate the steady-state level of molecular
chaperones through a pathway distinct from UPR [35], where-
in the induction kinetics were of the delayed early response
type, similar to that of TRAP K by GM-CSF. Investigating
the transcriptional elements that govern the expression of
TRAP K de¢nitely would tell us more about the detailed
mechanism of its induction.
Finally, our radiation hybrid mapping experiment localized
the TRAP K gene on the short arm of human chromosome 6,
the nearest marker being WI-4041. Interestingly, the genetic
susceptibility locus for schizophrenia has been mapped very
close to this marker [36^38]. A marker D6S296, to which the
highest lod score has been assigned in one study [37], is
mapped only 3 cR centromeric from WI-4041 according to
WICGR Mapping Service. Future studies will examine if
TRAP K is altered in schizophrenic patients.
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